Melatonin in circadian rhythm sleep disorders

Neuroendocrine Correlates of Sleep/Wakefulness

Volumn , Issue , 2006, Pages 269-294

  Srinivasan, V ^a   Smits, M G ^b   Kayumov, L ^c   Pandi Perumal, S R ^d   Cardinali, Daniel P ^e   Thorpy, M J ^f  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b Gelderse Vallei Hospital   (Netherlands)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745210014     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-23692-9_14     Document Type: Chapter

References (155)

1. J. Arendt, S. Deacon, J. English, S. Hampton, and L. Morgan, Melatonin and adjustment to phase shift, work hours, sleepiness and accidents, J Sleep Res A, 74 (1995).
2. J. Home and L. Reyner, Vehicle accidents related to sleep: a review, Occup Environ Med. 56, 289-294 (1999).
3. G. Atkinson, B. Drust, T. Reilly, and J. Waterhouse, The relevance of melatonin to Sports Medicine and Science, Sports Med. 33, 809-831 (2003).
4. L. Wetterberg, J Beck-Friis, and B F Kjellman. Melatonin acts as a marker for a sub group of depression in: Adults Biological rhythms, Mood disorders, Light therapy and Pineal gland (American Psychiatric Press Inc; Washington DC, 1990).
5. V. Srinivasan, Melatonin biological rhythm disorders and phototherapy, Ind J Physiol Pharmacol'. 41, 309-328 (1997).
6. S. W. Lockley, D. J. Skene, H. Tabandeh, A. C. Bird, R. Defrance, and J. Arendt, Relationship between napping and melatonin in blind, J Biol Rhythms. 12, 16-25 (1997).
7. L. Kayumov, G. Brown, R. Jindal, K. Butto, and C. M. Shapiro, A randomized double blind, placebo controlled cross over study of the effects of exogenous melatonin in delayed sleep phase syndrome, Psychosomatic Med. 63, 40-48 (2001).
8. A. J. Lewy, V. K. Bauer, S. Ahmed et al, The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light, Chronobiol MAS, 71-83 (1998).
9. J. Arendt, Importance and relevance of melatonin to biological rhythms, J Neuroendocrinol. 15, 1-5 (2003).
10. L. Kayumov, V. Zhdanova, and C. M. Shapiro, Melatonin, Sleep, and circadian rhythms disorders, Seminars in Clinical Neuropsychiatry. 5, 44-55 (2000).
11. T. Ninomiya, N. Iwatani, A. Tomoda, and T. Miike, Effects of exogenous melatonin on pituitary hormones in humans, Clin Physiol. 21(3), 292-299 (2001).
12. J. Arendt and J. Deacon, Treatment of circadian rhythm disorders-Melatonin, Chronobiol Int. 14, 185-204 (1997).
13. J. De Mairan, Observation botanique, Histoire de L'Academie Royale des Sciences., 35-36 (1729).
14. R. Y. Moore and D. C. Klein, Visual pathways and central neural control of circadian rhythms in pineal N acetyl transferase activity, Brain Res. 11, 17-33 (1974).
15. A. A. Sadun, J. D. Schaechter, and L. E. Smith, A retinohypothalamic pathway in man; light mediation of circadian Rhythms, Brain Res. 302, 371-377 (1984).
16. W. J. Hrushesky and G. A. Bjarnason, Circadian cancer therapy, J Clin Oncol A 1, 1403-1417 (1993).
17. A. Ayalon, H. Hermesh, and Y. Dagan, Case study of circadian rhythm sleep disorder following haloperidol treatment: reversal by risperidone and melatonin, Chronobiol Int. 19, 947-959 (2002).
18. M. Morris, L. Lack, and D. Dawson, Sleep onset insomniacs have delayed temperature rhythms, Sleep. 13, 1-14 (1990).
19. M. Gibertini, C. Graham, and M. R. Cook, Self report of circadian type reflects the phase of melatonin rhythm, Biol Psychol. 50, 19-33 (1999).
20. D. R. Wagner, Disorders of the circadian sleep-wake cycle, Neurol Clin. 14, 651-670 (1996).
21. R. L. Sack and A. J. Lewy, Circadian rhythm sleep disorders: lessons from the blind, Sleep Med Rev. 5, 189-206 (2001).
22. V. Srinivasan, Melatonin sleep-wakefulness rhythm and its disorders, Medical Nutritional Res Commun. 2, 1-8 (1994).
23. N. Zisapel, Circadian rhythim sleep disorders: pathophysiology and potential approaches to management, CNS DrugsA 5, 311-328 (2001).
24. D. Dawson and S. M. Armstrong, Chronobiotics - drugs that shift rhythms, Pharmacol Ther. 69, 15-36 (1996).
25. Y Dagan, I. Yovel, D. Hallis, M. Eisenstein, and I. Raichick, Evaluating the role of melatonin in the long-term treatment of delayed sleep phase syndrome DSPS, Chronobiol Int 15, 181-190 (1998).
26. P. Pevet, B. Bothorel, B. Slotten, and M. Saboureau, The chronobiotic properties of melatonin, Cell Tissue Res. 309, 183-191 (2002).
27. S. M. Armstrong, Melatonin the Internal zeitgeber of mammals, Pineal Res Rev. 1, 157-202 (1989).
28. D. P Cardinali and P. Pevet, Basic aspects of melatonin action, Sleep Med Rev. 2, 175-190 (1998).
29. D. C. Klein and R. Y. Moore, Pineal N acetyl transferase and hydroxy indole-O-methyl transferase. Control by retino hypothalamic tract and suprachiasmatic nucleus, Brain Res. 14, 245-254 (1979).
30. K. Thapan, J. Arendt, and D. Skene, An action spectrum for melatonin suppression; evidence for a novel non-rod, non-cone photoreceptor system in humans, J Physiol. 535, 261-267 (2001).
31. J. Z. Nowak and J. B. Zawliska, Melatonin and its physiological and therapeutic properties, Pharm World Sci, 20, 18-27 (1998).
32. T. Harumiand S. R. Pandi-Perumal. Pineal Gland and Melatonin Science, in: Application of chromatographic technique to the analysis of Melatonin and its related indoleamines, edited by C. Haider, M. Singaravel, and S. K. Maitra. (Publishers Inc Enfield, NH, USA, 2002) pp. 349-367.
33. D. C. Klein, S. L. Coon, P. H. Roseboom et al, The Melatonin rhythm generating enzyme molecular regulation of serotonin N-acetyltransferase in the pineal gland, Recent Progr Horm Res. 52, 307-357 (1997).
34. J. N. Mefford, P. Chang, D. C. Klein, M. A. Namboodiri, d. Sugden, and J. Barchas, Reciprocal day/night relationship between serotonin Oxidation and N-acetylation products in the rat pineal gland, Endocrinology. 113, 1582-1586
35. R. J. Reiter, Pineal Melatonin: Cell biology of its synthesis and of its physiological significance, Endocrine Rev 12, 151-180.
36. D. P. Cardinali, H. J. Lynch, and R. J. Wurtman, Binding of melatonin to human and rat plasma proteins, Endocrinology. 91, 1213-1218 (1972).
37. R. Nowak, I. C. McMillen, J. Redman, and R. V. Short, The correlation between serum and salivary melatonin concentration and urinary 6-hydroxy melatonin sulphate excretion rates; two non-invasive techniques for monitoring human Orcadian rhythmicity, Cin Endocrinology. 21, 445-452 (1987).
38. V. Srinivasan, Melatonin Oxidative stress and aging, Curr Sci. 16, 46-54 (1999).
39. M. L. Dubocovich, M. A. Rivera-Bermudez, M. J. Gerdin, and M. I. Masana, Molecular pharmacology, regulation and function of Mammalian melatonin receptors, Front Biosci. 8, D1093-D1108 (2003).
40. P. A. Witt-Enderby, J. Bennett, M. J. Jarzynka, S. Fires tine, and M. A. Melan, Melatonin receptors and their regulation: biochemical and structural mechanisms, Life Sci. 12, 2183-2198 (2003).
41. L. Naji, A. Carrillo-Vico, J. M. Guerrero, and J. R. Calvo, Expression of membrane and nuclear melatonin receptors in mouse peripheral organs, Life Sell 74, 2227-2236 (2004).
42. G. Benitez-King, A. Rios, A. Martinez, and F. Anton-Tay, In vitro inhibition of Ca2+/calmodulin-dependent kinase II activity by melatonin, Biochim Biophys Acta. 1290, 191-196 (1996).
43. R. J. Reiter, D. X. Tan, E. Gitto et al, Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage, PolJ Pharmacol. 56, 159-170 (2004).
44. Q. Wan, H. Q. Wan, F. Man et al, Differential modulation of GABA receptor function by Mel la and Mel lb receptors, Nat Neurosci. X, 401-403 (1999).
45. S. N. Archer, D. L. Robiliard, D. J. Skene et al, A length polymorphism in the Orcadian clock gene Per 3 is linked to delayed sleep phase syndrome and extreme diurnal preference, Sleep. 264, 413-415 (2003).
46. C. Gillin, E. Seifritz, R. K. Zoltoski, and R. J. Salin-Pascual. Basic science of Sleep, in: Comprehensive Text Book of Psychiatry, edited by B. J. Sadock and V. A. Sadock. 1. ed. (Lippincott Williams & Wilkins., Philadelphia, USA, 2000) pp. 199-209.
47. O. Tzischinsky, A. Shlitner, and P. Lavie, The association between the nocturnal sleep gate and the nocturnal onset of urinary 6-sulphatoxymelatonin, J Biol Rhythms. 8, 199-209 (1993).
48. I. V. Zhdanova and V. Tucci, Melatonin Orcadian rhythms and sleep, Curr Treat Opt Neurol. 5, 225-229 (2003).
49. B. M. Stone, C. Turner, S. L. Mills, and A. N. Nicholson, Hypnotic activity of melatonin, Sleep. 23, 663-669 (2000).
50. V. Zhdanova, R. J. Wurtman, C. Morabito, V. R. Piotrovska, and H. J. Lynch, Effects of low doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans, Sleep. 195, 423-431 (1997).
51. A. Cagnacci, J. Elliott, and S. Yen, Melatonin: a major regulator of the circadian rhythm of core body temperature in humans, J Clin Endocrinol Metab. 15, 447-452 (1992).
52. T. Shochat, R. Luboshitzky, and P. Lavie, Nocturnal melatonin onset is phase locked to primary sleep gate, Am J Physiol. 213(1 pt 2), R364-R370 (1997).
53. V. Srinivasan, The Pineal gland: its physiological and pharmacological role, IndJ Physiol Pharmacol. 33, 263-272 (1989).
54. T. A. Wehr, D. Aeschbach, and W. C. J. Duncan, Evidence for a biological dawn and dusk in human circadian timing system, J Physiol. 535, 937-951 (2001).
55. D. J. Dijk and C. A. Czeisler, Contribution of the circadian pacemaker and sleep homeostasis to sleep propensity, sleep structure, electroencephalographic slow waves, and spindle activity in humans, J Neurosci. 15, 3526-3538 (1995).
56. N. Zisapel, Development of a melatonin based formulation for the treatment of insomnia in the elderly, Drug Dev Res. 50, 226-234 (2000).
57. S. M. W. Rajaratnam and J. Arendt, Health in 24 hr society, Lancet. 358, 999-1005 (2001).
58. H. de Leersnyder, M. C. de Blois, M. Vekemas et al, Beta 1-adrenergic antagonists improve sleep and behavioral disturbances in a circadian disorder, Smith-Magenis syndrome, J Med Genet. 38(9), 586-590 (2001).
59. E. Aserinsky and N. Kleitman, Regularly occurring periods of eye motility, and concomitant phenomena during sleep, Science A 18(3062), 273-274 (1953).
60. S. W. Wurts, W. F. Seidel, W. C Dement, and D. M. Edger, Effects of suprachias-matic nucleus lesions on REM sleep continuity, Sleep Res. 26, 758 (1997).
61. D. Kunz and F. Bes, Melatonin as a therapy in REM sleep behaviour disorder patients: an open labeled pilot study on the possible influence of Melatonin on REM sleep regulation, Mov Disord. 14, 507-511 (1999).
62. D. Kunz, R. Mahlberg, C. Muller, A. Tilmann, and F. Bes, Melatonin in patients with reduced REM sleep duration: Two randomized controlled trials, J Clin Endocrinol Metab. 89, 128-134 (2004).
63. J. A. Home and O. Ostberg, A self-assessment questionnaire to determine morn-ingness-eveningness in human circadian rhythm, Int J ChronobiolA 2, 97-110 (1976).
64. A. K. Pati, A. Chandrawanshi, and A. Reinberg, Shift Work: Consequences and management, Curr SW. 81, 32-50 (2001).
65. M. G. Smits, H. F. van Stel, H. K. van der, A. M. Coenen, and G. A. Kerkhof, Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial, J Am Acad Child Adolesc Psychiatry. 4211, 1286-1293 (2003).
66. H. Yamadera, K. Takahashi, and M. Okawa, A multicenter study of sleep-wake rhythm disorders: therapeutic effects of vitamin B 12, bright light therapy, chronotherapy and hypnotics, Psychiatry Clin Neurosci. 50, 203-209 (1996).
67. E. D. Weitzman, C. A. Czeisler, R. M. Coleman et al, Delayed sleep phase syndrome. A chronobiologic disorder with sleep onset insomnia, Arch Gen Psychiat. 38(1), 737-746 (1981).
68. Y. Dagan, D. Stein, M. Steinbock, I. Yovel, and D. Hallis, Frequency of delayed sleep phase syndrome among hospitalized adolescent psychiatric patients, J Psychosom Res. 45, 15-20 (1998).
69. Y. Dagan and M. Eisenstein, Circadian rhythm sleep disorders; towards more precise definition and diagnosis, Chronobiol IntA 6, 213-222 (1999).
70. M. Hori and T. Asada, Life-style regularity and core body temperature phase in delayed sleep phase syndrome, Sleep and Biological Rhythms. 1, 251-552 (2003).
71. T. Watanabe, N. Kajimura, M. Kato et al, Sleep and circadian rhythm disturbances in patients with delayed sleep phase syndrome, Sleep. 26, 657-661 (2003).
72. Q. R. Regestein and T. H. Monk, Delayed sleep phase syndrome: a review of its clinical aspects, Amer Jpsychiat. 152, 602-628 (1995).
73. M. J. Thorpy. Diagnostic classification of sleep disorders Diagnostic and coding manual 1990).
74. R. Rosenberg. Case studies in Insomnia, in: Assessment and treatment of delayed sleep phase syndrome, edited by P. J. Hauri. (Plenum, New York, 1991) pp. 193-205.
75. K. Shibui, M. Uchiyama, K. Kim et al, Melatonin, Cortisol and thyroid-stimulating hormone rhythms are delayed in patients with delayed sleep phase syndrome, Sleep and Biological Rhythms A, 209-214 (2003).
76. M. Yazaki, S. Shirakawa, M. Okawa, and K. Takahashi, Demography of sleep disturbances associated with circadian rhythm disorders in Japan, Psychiatry Clin Neurosci. 53, 261-268 (1999).
77. R. P. Pelayo, M. J. Thorpy, and P. Glovinsky, Prevalence of delayed sleep phase syndrome among adolescents, J Sleep Res 17, 392 (1988).
78. Q. R. Regestein and M. Pavlova, Treatment of delayed sleep phase syndrome, Gen Hosp Psychiat 17, 335-345 (1995).
79. M. J. Thorpy, E. Korman, A. J. Speilman, and P. B. Glovinsky, Delayed sleep phase syndrome in adolescents, J Adolesc Health Care. 9, 22-27 (1988).
80. H. Schrader, G. Bovim, and T. Sand, The prevalence of delayed and advanced sleep phase syndromes, J Sleep Res. 2, 51-55 (1993).
81. C. Quinto, C. Gellido, S. Chokroverty, and J. Masdeu, Posttraumatic delayed sleep phase syndrome, Neurology. 54, 250-252 (2000).
82. J. E. Nagtegaal, G. A. Kerkhof, M. G. Smits, A. C. Swart, and Y. G. van der Meer, Traumatic brain injury associated sleep phase syndrome, Func Neurol. 126, 345-348 (1997).
83. M. G. Smits and J. E. Nagtegaal, Posttraumatic delayed sleep phase syndrome, Neurology. 55, 902-903 (2000).
84. M. Shirayama, Y. Shirayama, H. Iida et al, The psychological aspects of patients with delayed sleep phase syndrome DSPS, Sleep Medicine. 4, 427-433 (2003).
85. M. G. Smits, R. V. Rooij, and J. E. Nagtegaal, Influence of melatonin on Quality of life in patients with chronic fatigue and late melatonin onset, JCFS. 48, 45-50 (2002).
86. M. Shibui, M. Uchiyama, and M. Okawa, Melatonin rhythms in delayed sleep phase syndrome, J Biol Rhythms 14, 72-76 (1999).
87. N. Cermakian and D. B. Boivin, A molecular perspectives of human circadian rhythms disorders, Brain Res RevA 2, 204-220 (2003).
88. T. Ebisawa, M. Uchiyama, N. Kajimura et al, Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome, EM BO Reports. 21, 342-346 (2001).
89. K. L. Toh, C. R. Jones, Y. He et al, An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome, Science. 291, 1040-1043 (2001).
90. C. A. Czeisler, G. S. Richarson, R. M. Coleman et al, Chronotherapy: resetting the circadian clocks of patients with delayed sleep phase insomnia, Sleep 4(1), 1-21 (1981).
91. A. J. Lewy, R. L. Sack, L. S. Miller et al, The use of plasma melatonin levels and light in the assessment and treatment of chronobiologic sleep and mood disorders, J Neural Trans Suppl. 21, 311-322 (1986).
92. M. G. Smitsand, S. R. Pandi-Perumal. Delayed sleep phase syndrome: a melatonin onset disorder, in: Melatonin: Biological basis of its function in health and disease, edited by S. R. Pandi-Perumal and D. P. Cardinali. (2004).
93. R. E. Rosenthal, J. R. Joseph-Vanderpool, A. A. Levendosky et al, Phase-shifting effects of morning light as treatment for delayed sleep phase syndrome, Sleep. 134, 354-361 (1990).
94. S. S. Campbell, P. J. Murphy, C. J. van den Heuvel, M. L. Roberts, and T. N. Stauble, Etiology and treatment of intrinsic circadian rhythm sleep disorders, Sleep Med Rev. 3, 179-200 (1999).
95. M. Okawa, K. Mishima, T. Nanami et al, Vitamin B 12 treatment for sleep-wake rhythm disorders, Sleep. 131, 15-23 (1990).
96. D. Dahlitz, B. Alvarez, J. Vignau, J. English, J. Arendt, and J. D. Parks, Delayed sleep phase syndrome, response to melatonin, Lancet. 337 8750, 1121-1124 (1991).
97. B. Alvarez, M. J. Dahlitz, J. Vignou, and J. D. Parkes, The delayed sleep phase syndrome: clinical and investigative findings in 14 subjects, J Neurol Neurosurg Psychiat. 55, 665-670 (1992).
98. A. J. Lewy, S. Ahmed, J. M. Jackson, and R. L. Sack, Melatonin shifts human circadian rhythms according to a phase response curve, Chronobiol Int. 9, 380-392 (1992).
99. J. E. Nagtegaal, G. A. Kerkhof, M. G. Smits, A. C. Swart, and Y. G Deer Meer, Delayed sleep phase syndrome; A placebo controlled crossover study on the effects of melatonin administered five hours before the individuals dim light Melatonin onset, J Sleep Res. 1, 135-143 (1998).
100. M. G Smits, J. E. Nagtegaal, J. Van der Heijiden, A. M. Coenen, and G A. Kerkhof, Melatonin for chronic sleep onset insomnia in Children: a randomized placebo controlled trial, J Child Neurol. 162, 86-92 (2001).
101. S. Kemp, R. Biswas, V Neumann, and A. Coughlan, The value of Melatonin for sleep disorders occurring post head injury a pilot RCT, Brain Inj. 189, 911-919
102. S. M. Armstrong and J. R. Redman, Melatonin: a chronobiotic with anti-aging properties, Medical hypothesis. 34, 300-309 (1199).
103. C. R. Jones, S. S. Campbell, S. E. Zone et al, Familial advanced sleep-phase syndrome: a short-period circadian rhythms variant in humans, Nature Med. 5, 1062-1065 (1999).
104. K. J. Reid, A. M. Chang, M. L. Dubocovich, F. W. Turek, J. S. Takahashi, and P. C. Zee, Familial advanced sleep-phase syndrome, Arch Neurol. 587, 1089-1094 (2001).
105. K. Ando, D. F. Kripke, and S. Ancoli-Israel, Delayed and advanced sleep phase symptoms, Isr J Psychiat Relat Sci. 39, 11-18 (2002).
106. C. A. Czeisler, R. E. Kronauer, J. S. Mooney, J. L. Anderson, and J. S. Allain. Biological rhythm disorders, depression and phototherapy. A new hypothesis Psychiatric clinics of North America, edited by M. K. Erman. (W B Saunders company, Phildelphia USA, 1987) pp. 687-709.
107. R. J. Reiter. Pineal rhythmicity, Neural, behavioral and endocrine consequences, in: Biological rhythms, Mood disorders and Light therapy, edited by M. Shafii and S. Shaffi. (American Psychiatric Press Inc, Washington DC, 1990) pp. 41-66.
108. D. Leger, M. Lauden, and N. Zisapel, Nocturnal 6-sulfatoxy melatonin excretion in insomnia and its relation to the response to melatonin replacement therapy, Am JMed. 116, 91-95 (2004).
109. M. Zucconi, Familial advanced sleep-phase syndrome, Sleep Medicine. 3, 177-178 (2002).
110. K. Satoh, K. K. Mishima, Y. Inoue, T. Ebisawa, and T. Shimuzu, Two pedigrees of familial advanced sleep phase syndrome in Japan, Sleep. 264, 416-417 (2003).
111. K. J. Reid, A. M. Chang, and P. C. Zee, Circadian rhythm sleep disorders, Med Clin N Am 88, 631-651 (2004).
112. L. I. Brusco, M. Marquez, and D. P. Cardinali, Monozygotic twins with Alzheimer's disease treated with melatonin: Case report, Journal of Pineal Research. (1998).
113. L. I. Brusco, M. Marquez, and D. P. Cardinali, Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease, Neuroendocrinology Letters. 19, 111-115 (1998).
114. D. P. Cardinali, L. I. Brusco, C. Liberczuk, and A. M. Furio, The use of melatonin in Alzheimer's disease, Neuroendocrinology Letters. 23(suppl. 1), 26-29 (2002).
115. K. Asayama, H. Yamadera, T Ito, H. Suzuki, Y. Kudo, and S. Endo, Double blind study of melatonin effects on the sleep-wake rhythm cognitive and Non-cognitive functions in AlzheimerÆs Type dementia, J Nippon Med Sch. 10, 334-341 (2003).
116. K. Mishima, T. Tozawa, K. Satoh, Y. Matsumoto, Y Hishikawa, and M. Okawa, Melatonin secretion rhythm disorders in senile Dementia of AlzheimerÆs Type with disturbed sleep-waking, Biol Psychiatry. 45, 417-421 (1999).
117. J. Arendt and V. Marks, Physiological changes underlying Jet lag, Brit Med J. 284, 141-146 (1982).
118. A. O. Jamieson, G. K. Zammit, R. S. Rosenberg, J. R. Davis, and J. K. Walsh, Zolpidem reduces the sleep disturbance of Jetlag, Sleep Med. 2(5), 423-430 (2001).
119. B. L. Parry, Jetlag; minimizing its effects with critically timed bright light and melatonin administration, J Mol Microbiol Biotechnol. 4(5), 463-466 (2002).
120. S. Deacon and J. Arendt, Melatonin induced temperature suppression and its acute phase shifting effects correlate in a dose dependent manner in humans, Brain Res. 688, 77-85 (1995).
121. J. Arendt, J. Aldhous, and V. Marks, Alleviation of jet lag by melatonin. Preliminary results of double blind trial, Brit Med J. 292, 1170 (1986).
122. G. F. Oxenkrug and P. J. Requintina, Melatonin and jet lag syndrome: Experimental model and clinical implications, CNS Spect. 82, 139-148 (2003).
123. D. P. Cardinali, L. I. Brusco, S. Perez Lloret, and A. M. Furio, Melatonin in sleep disorders and jet-lag, Neuroendocrinology Letters. 23(suppl. 1), 13-17 (2002).
124. T. Takahashi, M. Sasaki, H. Itoh et al, Melatonin alleviates jet lag symptoms caused by an 11-hour eastward flight, Psychiatry Clin Neurosci. 56, 301-302 (2002).
125. D. P. Cardinali, G. P. Bortman, G. Liotta et al, A multifactorial approach employing melatonin to accelerate resynchronization of sleep-wake cycle after a 12 time-zone westerly transmeridian flight in elite soccer athletes, J Pineal Res. 32, 41-46 (2002).
126. A. E. Reinbergand, M. H. Smolensky. Biological rhythms in clinical and laboratory medicine, in: Night shift work, transmeridian and space flights, edited by Y Touitou and E. Haus. (Springer-Verlag, Germany, 1992) pp. 243-255.
127. T. Akerstedt, Work hours, sleepiness and underlying mechanism, Sleep Res 4, 15-22 (1995).
128. C. A. Czeisler, M. P. Johnson, J. E. Duffy, E. N. Brown, J. M. Ronda, and R. E. Kronauer, Exposure to bright light and darkness to treat physiologic mal-adaptation to night shift work, N Eng J Med. 322, 1253-1259 (1990).
129. S. Folkard, J. Arendt, and M. Clark, Can melatonin improve shift-workers tolerance to night shift? Some preliminary findings, Chronobiol Int 10, 315-320 (1993).
130. R. Sack and A. Lewy, Melatonin as a chronobiotic: treatment of circadian desynchrony in night workers and the blind, J Biol Rhythms. 12, 595-603 (1997).
131. M. A. Quera-Salva, C. Guilleminault, B. Claustrat et al, Rapid shift in peak melatonin secretion associated with improved performance in short shift work schedule, Sleep. 2012, 1145-1150 (1997).
132. S. M. W. Rajaratnam, D. J. Dijk, B. Middleton, and B. M. Stone, Melatonin phase shifts Human circadian Rhythms with no evidence of changes in the duration of endogenous melatonin secretion or the 24-hour production of reproductive hormones, J Clin Endocrinol Metab. 88, 4303-4309 (2003).
133. H. Nakagawa, R. L. Sack, and A. J. Lewy, Sleep propensity free-runs with the temperature, melatonin and Cortisol rhythms in a totally blind person, Sleep. 15, 330-336 (1992).
134. S. W. Lockley, D. J. Skene, K. James, K. Thapen, J. Wright, and J. Arendt, Melatonin administration can entrain the free running circadian system of blind subjects, J Endocrinol. 1641, R1-R6 (2000).
135. R. L. Sack, R. W Brandes, A. R. Kendall, and A. J. Lewy, Entrainment of free running circadian rhythms by melatonin in blind people, N Eng J Med. 343(15), 1070-1077 (2000).
136. J. Arendt, Melatonin, circadian rhythms and sleep, N Eng J Med. 34, 1114-1116 (2000).
137. K. Shibui, M. Okawa, M. Uchiyama et al, Continuous measurement of temperature in non-24 hour sleep-wake syndrome, Psychiatry Clin Neurosci. 52(2), 236-237 (1998).
138. Y. Kamei, J. Urata, M. Uchiyaya et al, Clinical characteristics of circadian rhythm sleep disorders, Psychiatry Clin Neurosci. 52(2), 234-235 (1998).
139. A. L. Eliott, J. N. Mills, and J. M. Waterhouse, A man with too long a day, J Physiol London. 212, 30-31 (1970).
140. T. M. Hoban, R. L. Sack, A. J. Lewy, L. S. Miller, and C. M. Singer, Entrainment of a free-running human with bright light?, Chronobiol Int. 6, 347-353 (1989).
141. A. J. McArthur, A. J. Lewy, and R. L. Sack, Non-24-hour sleep-wake syndrome in a sighted man: circadian rhythm studies and efficacy of melatonin treatment, Sleep. 19, 544-553 (1996).
142. D. A. Oren, H. A. Giesen, and T. A. Wehr, Restoration of detectable melatonin after entrainment to a 24-hour schedule in a "free-running" man, Psychoneuroendo-crinology. 22, 39-52 (1997).
143. Y. T. O. Kayukawa, Epidemiology of circadian rhythm sleep disorders, Study on the diagnosis, treatment and epidemiology of sleep disorders. Annual Report of the National Project Team 1995, 131-135 (1995).
144. L. Kayumov, G. Brown, R. Jindal, K. Buttoo, and C. M. Shapiro, A randomized, double-blind, placebo-controlled crossover study of the effects of exogenous melatonin on delayed sleep phase syndrome, Psychosom Med. 63, 40-48 (2001).
145. T. A. Wehr, R. Sack, N. Rosenthal, W. Duncan, and J. C. Gillin, Circadian rhythm disturbances in manic-depressive illness, Fed Proceed'. 42, 2809-2814 (1983).
146. L. Wetterberg, The pineal hormone melatonin as marker for a subgroup of depression, Medicographica. 1, 4-7 (1986).
147. L. Wetterberg, J. Beck-Friis, B. Aperia, and U. Petterson, Melatonin Cortisol ratio in depression, Lancet. 2, 1361 (1979).
148. A. Venkobarao, S. Parvathi devi, and V. Srinivasan, Urinary melatonin in depression, Ind J Psychiat. 25, 167-172 (1983).
149. A. Mayedaand, J. Nurnberger. Biological rhythms, mood disorders, Light therapy and Pineal gland, in: Melatonin and circadian rhythms in Bipolar disorder, edited by M. Shafii and S. Shafii. (American Psychiatric Press Inc., Washington DC USA, 1990) pp. 119-137.
150. N. E. Rosenthal, R. A. Sack, J. C. Gillin et al, Seasonal affective disorder; A description of the syndrome and preliminary findings with light therapy, Arch Gen Psychiat. 41, 72-80 (1984).
151. A. Wirz-Justice, P. Graw, K. Krauchi et al, Natural light treatment of seasonal affective disorder, J Affective Dis 31, 109-120 (1996).
152. D. A. Oren, Retinal melatonin and dopamine in seasonal affective disorder, J neural transmission. 83, 85-95 (1991).
153. O. T. Dolberg, S. Hirschmann, and L. Grunhaus, Melatonin for the treatment of sleep disturbances in major depressive disorder, Am J Psychiat. 155, 1119-1121 (1998).
154. I. Fainstein, A. Bonetto, L. I. Brusco, and D. P. Cardinali, Effects of melatonin in elderly patients with sleep disturbance. A pilot study., Curr Ther Res. 58, 990-1000 (1997).
155. M. Crasson, S. Kjiri, A. Colin et al, Serum melatonin and urinary 6-sulfatoxy melatonin in major depression, Psychoneuroendocrinology. 291, 1-12 (2004).